PharmD Live

JUNE 23, 2025

This 2025 vendor landscape review highlights how PharmD Live stands out by combining pharmacist-led clinical expertise, AI-powered insights, and fully CMS-aligned virtual care services, delivering tangible, reportable results across complex patient populations. PharmD Live is uniquely positioned in 2025 to meet these needs.

HIPAA

Hospital Pharmacy Europe

APRIL 24, 2025

It involved pharmacist, hospital doctor and GP training on delivering structured medicine reviews and managing inappropriate polypharmacy. iMPROVE Launched on 1 March 2025, MOICs latest project is Innovation in person-centred Medication Prescribing and Review for Optimal Value and Efficacy (iMPROVE). June 2023 [Accessed April 2025].

Nursing Homes

Hospital Pharmacy Europe

JUNE 12, 2025

Noting a concerning vacancy rate, the pharmacy department at East Kent Hospitals University NHS Foundation Trust set about determining the reasons for this and identifying solutions. One respondent said flexible working reduced communication and another felt there was reduced resilience in the team.

Hospitals

Pharmaceutical Technology

AUGUST 5, 2025

Robert Barrie August 5, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook In 2023, a record 85,000 cases of the disease were reported in England — three times higher than in 2012. Known under the brand name Blujepa, the drug was approved in the US to treat urinary tract infections in March 2025.

Vaccines

Drug Topics

JULY 18, 2025

Hospitalization occurs in 1% to 4% of cases, mostly involving immunocompromised individuals. July 17, 2025. Accessed July 18, 2025. Accessed July 18, 2025. Accessed July 18, 2025. Accessed July 18, 2025. While most experience shingles only once, recurrence is possible. News Release. October 23, 2017.

Vaccines

Pharmaceutical Technology

JUNE 13, 2025

June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Login Registration is disabled.

Vaccines

Pharmaceutical Technology

JULY 28, 2025

July 28, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook HRS-9821 aligns with GSK’s goal to address a broad spectrum of COPD patients. In March 2025, MSD entered an exclusive licence agreement with Hengrui Pharma for the investigational oral small-molecule lipoprotein(a) [Lp(a)] inhibitor, HRS-5346.

Packaging

Pharmaceutical Technology

JUNE 25, 2025

June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook BP is a chronic skin disease marked by severe itching, painful blisters, lesions and skin redness. In February 2025, the FDA accepted Dupixent’s supplemental biologics licence application (sBLA) for priority review. Credit: Toa55/Shutterstock.

FDA

Pharmaceutical Technology

JUNE 12, 2025

GlobalData Healthcare June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook European KOLs with cardiomyopathy patients told GlobalData that they are waiting for vutrisiran’s launch for ATTR-wt. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JUNE 19, 2025

GlobalData Healthcare June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The oligonucleotide market is well-positioned to drive the next wave of personalised treatment. billion from 2021 to 2025 year-to-date. Credit: Kateryna Kon via Shutterstock. ASOs accounted for more than half ($3.54

Communication

Pharmaceutical Technology

JULY 30, 2025

July 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook MP1032 is intended for treating Duchenne muscular dystrophy. Credit: luchschenF/Shutterstock.com. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Login Registration is disabled.

Packaging

Drug Topics

AUGUST 8, 2025

1 READ MORE: Infections for Measles, Bird Flu, and Pertussis Increase in 2025 In China, where AMR is also on the rise, their systems for facilitating ASPs are complex and create difficulty for pharmacists and other providers to provide care. 2025 Jul 28;18:3735-3744. Accessed August 8, 2025. February 4, 2025.

Specialty Pharmacies

Pharmaceutical Technology

JUNE 6, 2025

June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will support clinical milestones along with AI-driven development across Juvenescence’s portfolio. The acquisition forms a key part of Juvenescence’s partnership with the Abu Dhabi global healthcare company M42, which was announced in April 2025.

Communication

Pharmaceutical Technology

JUNE 10, 2025

June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will be used to advance Mosanna’s nasal spray for obstructive sleep apnoea. Credit: Pixel-Shot/Shutterstock. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Communication

Pharmacy Times

AUGUST 7, 2025

The FDA has announced changes to the labeling of all opioid pain medications, including immediate-release and extended-release, to better communicate long-term risks like abuse, addiction, overdose, and drug interactions, according to a news release from the agency. Published 2025. Accessed August 1, 2025. REFERENCES 1.

Labelling

Pharmaceutical Technology

JUNE 6, 2025

June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The authorisation in the EU signifies a step forward in eye care for paediatric patients. Credit: chaponta/Shutterstock. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Communication

Pharmacy Times

JULY 24, 2025

To me, it’s positioning this in terms of how quickly these patients benefit from it, and if it’s 7 days then in my opinion, start it in the hospital.” The FDA’s Prescription Drug User Fee Act date for finerenone is in July 2025. March 17, 2025. Accessed June 27, 2025. News release. Subscribe Now!

HIV Treatment and Prevention Agents

Pharmacy Times

JUNE 13, 2025

Image credit: zinkevych | stock.adobe.com Of note, the discussion primarily focused on the community side of pharmacy—rather than the hospital or institutional settings. Presented at: American Association of Pharmacy Technicians 2025 Annual Pharmacy Technician Convention. Denver, CO. Subscribe Now!

Compounding Pharmacies

Pharmaceutical Technology

JULY 28, 2025

GlobalData Healthcare July 28, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Credit: Vitalii Vodolazskyi / Shutterstock.com. CAGR is largely attributed to the launch of novel biologics and small molecules. Give your business an edge with our leading industry insights. Login Registration is disabled.

Packaging

Pharmaceutical Technology

JUNE 20, 2025

June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The MoU was signed at the BIO International Convention 2025 in Boston, US. The MoU was signed at the BIO International Convention 2025 in Boston, in the US state of Massachusetts. Credit: Department of Health Abu Dhabi.

Vaccines

Pharmaceutical Technology

JUNE 23, 2025

June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook argenx is collaborating with regional regulatory authorities to facilitate patient access to the treatment. Credit: Wirestock Creators/Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.

Communication

Pharmacy Times

JULY 28, 2025

2 In addition, VFC prevented more than 32 million hospitalizations and 1.1 Accessed May 29, 2025. Communicating with vaccine-hesitant parents: a narrative review. Accessed May 29, 2025. million premature deaths. September 20, 2024. link] Kumar S, Shah Z, Garfield S. Vaccines (Basel). 2022;10(9):1518. Acad Pediatr.

Vaccines

Pharmaceutical Technology

JULY 29, 2025

Abigail Beaney July 29, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The JAK1 inhibitor is already approved in RA and UC. Galapagos contributed around €40m to Alfasigma by June 2025 for Jyseleca development. Image credit: 3dMediSphere / Shutterstock.com. Sign up for our daily news round-up!

Packaging

Pharmaceutical Technology

JULY 30, 2025

A first-in-human Phase I study involving patients with relapsed or refractory B-cell lymphoma is expected to commence using AVC-203 in the second half of 2025. We may still continue to send you service-related and other non-promotional communications. Credit: PanuShot/Shutterstock.com. Sign up for our daily news round-up!

Communication

Pharmaceutical Technology

JUNE 18, 2025

June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Orion will obtain access to Glykos’ ADC technologies for probable expansion into three new programmes. Credit: Premreuthai/Shutterstock. Sign up for our daily news round-up! Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JUNE 10, 2025

June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Enflonsia is administered to infants with the same dose regardless of their bodyweight. Credit: MargJohnsonVA/Shutterstock. “We Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

FDA

Pharmacy Times

JUNE 17, 2025

SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. If a discrepancy is found, the pharmacy nurses will hold the shipment, and a clinical intervention will be communicated to the provider.

Mail-Order Pharmacies

Pharmaceutical Technology

JULY 21, 2025

July 21, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The acquisition of Blueprint provides Sanofi with a well-established foothold among allergists, dermatologists and immunologists. In June 2025, Sanofi agreed to acquire Blueprint for an equity value of $9.1bn. Sign up for our daily news round-up!

Packaging

Pharmacy Times

JUNE 11, 2025

Image Credit: © Chinnapong - stock.adobe.com At the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025, an encore presentation from the Pacific Coast Reproductive Society Annual Meeting will highlight findings from a retrospective analysis conducted by Walgreens Specialty Pharmacy.

Specialty Pharmacies

The Nontraditional Pharmacist

JULY 1, 2025

It’s 2025. And those are sites, sometimes those are hospitals, sometimes they’re physician’s offices, there’s for-profit, clinical research sites out there. So, good talking to you. Matt Paterini (01:21): No, we appreciate the time. And remember, COVID was in there too, right? So, we would have spoken in 2019.

FDA

Pharmaceutical Technology

JUNE 17, 2025

Abigail Beaney June 17, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook With potential tariffs and other changes in the US market, it is important for European companies to show they have a scalable model if they want to break into the market. Give your business an edge with our leading industry insights.

Communication

Pharmacy Times

JUNE 20, 2025

These job duties each require different skill sets, from writing and verbal communication to process development, technical aptitude, and deep clinical expertise. Accessed May 15, 2025. Accessed May 15, 2025. Accessed May 15, 2025. Accessed May 15, 2025. However, one person cannot do all these things well.

Compounding

Hospital Pharmacy Europe

APRIL 14, 2025

Key findings in this review emphasised that most of these children and young people died before reaching the hospital, with 46% receiving inadequate asthma care. Some deaths occurred due to cardiac arrest, predominantly outside of hospitals, with 29 children (58%) having unsuccessful cardiopulmonary resuscitation.

Health and Personal Care Stores

Pharmaceutical Technology

JUNE 23, 2025

June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook HBM7020 activates immune system T cells to target and destroy B cells and plasma cells involved in many autoimmune diseases. We may still continue to send you service-related and other non-promotional communications. Sign up for our daily news round-up!

Communication

Pharmacy Times

JULY 7, 2025

We are communicating this information now to allow time for patients to work closely with their health care teams to develop alternative treatment plans.” Released June 30, 2025. Accessed July 7, 2025. Accessed July 7, 2025. Published February 21, 2025. Accessed July 7, 2025. News Release. Rupa Health.

FDA

Pharmacy Times

JUNE 8, 2025

At the American Society of Health-System Pharmacists (ASHP) Pharmacy Futures 2025 meeting, presenter Madison Wood, PharmD, CPh, BCPS, reviewed a groundbreaking model for integrating specialty pharmacists directly into neurology care teams. Within this expansive network, the neurology clinical pharmacy specialist serves a vital dual role.

Patient Care

Pharmaceutical Technology

JULY 22, 2025

July 22, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook PsO is an immune-mediated disease characterised by rapid skin cell proliferation leading to inflamed plaques that can cause discomfort or pain. Give your business an edge with our leading industry insights.

FDA